I’m not going to rehash what Robert Gurley pointed out, but your connection to Epi Pen’s raised prices being a function of the free market is either dishonest or you’re too uninformed to write about it.

Remember when Shkreli’s company increased the price of Diaprim to a ridiculous price? Free market competition had a comparable $1 pill on the market in less than a week.